Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TIC
2576
TIC Solutions Inc
TIC
$1.8B
| $3.15M | ﹤0.01% |
311,319
+71,323
| +30% | +$794K |
2025 Q2
2 quarters
|
|
2577
iShares US Technology ETF
IYW
$27B
| $3.14M | ﹤0.01% |
15,750
+13,944
| +772% | +$2.79M |
2024 Q1
7 quarters
|
|
2578
CorVel
CRVL
$3.81B
| $3.14M | ﹤0.01% |
46,340
+4,648
| +11% | +$337K |
2013 Q2
50 quarters
|
|
2579
DHT Holdings
DHT
$3.82B
| $3.13M | ﹤0.01% |
256,544
+24,171
| +10% | +$304K |
2016 Q2
38 quarters
|
|
2580
Vista Energy
VIST
$7.11B
| $3.13M | ﹤0.01% |
64,293
+6,704
| +12% | +$303K |
2024 Q4
4 quarters
|
|
|
CIVI
2581
DELISTED
Civitas Resources
CIVI
| $3.12M | ﹤0.01% |
115,326
-670,016
| -85% | -$19.4M |
2022 Q1
15 quarters
|
|
|
LADR
2582
Ladder Capital
LADR
$1.09B
| $3.12M | ﹤0.01% |
283,560
+88,958
| +46% | +$966K |
2014 Q1
47 quarters
|
|
2583
PagSeguro Digital
PAGS
$2.49B
| $3.12M | ﹤0.01% |
323,139
-12,685
| -4% | -$122K |
2021 Q3
17 quarters
|
|
2584
Nicolet Bankshares
NIC
$3.49B
| $3.11M | ﹤0.01% |
25,680
+5,791
| +29% | +$732K |
2016 Q3
37 quarters
|
|
|
OS
2585
DELISTED
OneStream Inc
OS
| $3.11M | ﹤0.01% |
169,314
+20,428
| +14% | +$389K |
2024 Q3
5 quarters
|
|
2586
Eldorado Gold
EGO
$9.94B
| $3.11M | ﹤0.01% |
86,570
-18,130
| -17% | -$543K |
2013 Q2
50 quarters
|
|
2587
Minerals Technologies
MTX
$2.07B
| $3.11M | ﹤0.01% |
50,979
+2,171
| +4% | +$129K |
2013 Q2
50 quarters
|
|
2588
CALL
Bristol-Myers Squibb
BMY
$125B
| $3.11M | ﹤0.01% |
57,600
+20,300
| +54% | +$977K |
2025 Q2
2 quarters
|
|
2589
CALL
T-Mobile US
TMUS
$176B
| $3.11M | ﹤0.01% |
15,300
| – | – |
2025 Q3
1 quarter
|
|
2590
CareDx
CDNA
$3.47B
| $3.1M | ﹤0.01% |
164,413
-22,482
| -12% | -$377K |
2017 Q4
32 quarters
|
|
2591
Innodata
INOD
$2.41B
| $3.09M | ﹤0.01% |
60,743
+14,099
| +30% | +$920K |
2023 Q1
11 quarters
|
|
2592
PureCycle Technologies
PCT
$882M
| $3.09M | ﹤0.01% |
359,934
+173,989
| +94% | +$1.85M |
2022 Q1
15 quarters
|
|
2593
PUT
Builders FirstSource
BLDR
$6.05B
| $3.09M | ﹤0.01% |
30,000
| – | – |
2025 Q1
3 quarters
|
|
2594
PENN Entertainment
PENN
$1.98B
| $3.09M | ﹤0.01% |
209,250
+21,936
| +12% | +$342K |
2013 Q2
50 quarters
|
|
2595
Spectrum Brands
SPB
$1.8B
| $3.08M | ﹤0.01% |
52,135
+2,785
| +6% | +$157K |
2015 Q2
42 quarters
|
|
2596
PUT
Applied Digital
APLD
$7.59B
| $3.08M | ﹤0.01% |
125,600
-196,200
| -61% | -$5.65M |
2025 Q3
1 quarter
|
|
2597
Iovance Biotherapeutics
IOVA
$6.44B
| $3.08M | ﹤0.01% |
1,127,157
+190,470
| +20% | +$441K |
2019 Q1
27 quarters
|
|
2598
Diamondrock Hospitality Co
DRH
$2.57B
| $3.07M | ﹤0.01% |
342,733
-51,594
| -13% | -$440K |
2013 Q2
50 quarters
|
|
2599
Stock Yards Bancorp
SYBT
$2.44B
| $3.06M | ﹤0.01% |
47,076
+8,134
| +21% | +$547K |
2016 Q1
39 quarters
|
|
2600
Janux Therapeutics
JANX
$1.04B
| $3.05M | ﹤0.01% |
221,233
+77,209
| +54% | +$1.82M |
2022 Q1
15 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.